Arabic
English
Quick links
Government sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password?

    1
    ...
    148
    149
    150
    151
    152
    153
    ...
    201
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC brand_name B/G Ingredients Dosage Form Price
J07CA06 INFANRIX IPV + HIB B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 3,014,239 L.L
M01AH07 ACELEX B Polmacoxib - 2mg 2mg Capsule 2,600,655 L.L
J07AL02 PREVENAR 13 B Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 6,863,004 L.L
J07AL02 SYNFLORIX B Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg Injectable suspension 4,675,228 L.L
J07AH08 NIMENRIX B Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml Injectable lyophilised powder for solution+diluent 4,483,059 L.L
J07AL01 PNEUMOVAX 23 B Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml Injectable solution 2,409,510 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 10,462,270 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 10,462,270 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 10,462,270 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 10,462,270 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 3mg 3mg Capsule, hard 10,865,805 L.L
L04AX06 IMNOVID B Pomalidomide - 3mg 3mg Capsule, hard 10,865,805 L.L
L04AX06 IMNOVID B Pomalidomide - 3mg 3mg Capsule, hard 662,450,757 L.L
L04AX06 IMNOVID B Pomalidomide - 3mg 3mg Capsule, hard 662,450,757 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 10,865,805 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 10,865,805 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 662,450,757 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 662,450,757 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 103,555,986 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 273,595,736 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 4,487,636 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 4,487,636 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 207,092,603 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 451,674,162 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 7,408,556 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 7,408,556 L.L
    1
    ...
    148
    149
    150
    151
    152
    153
    ...
    201
Sitemap
© Copyrights reserved to Ministry of Public Health 2024